Recent Publications

Analytical Methods

February 15, 2018

July 14, 2017

Survey And Real-World Data: A Winning Combination

by Peter Simon, Kristina Shampanier, Riddhima Sharma and Rebecca Kirk Fair

September 22, 2016

Practical Uses For Machine Learning In Health Care Cases

by Mihran Yenikomshian, Lisa B. Pinheiro, Jimmy Royer and Paul E. Greenberg

June 8, 2016

Machine-Learning Algorithms Can Help Health Care Litigation

by Lisa B. Pinheiro, Jimmy Royer, Nick Dadson and Paul E. Greenberg

August 14, 2014

Big Data Can Yield Big Insights On Promotional Practices

by Paul E. Greenberg and Tamar Sisitsky

Antitrust

December 18, 2018

The State Of Pharma Class Certification After Asacol

by Aaron Yeater, Pavel Darling and Stephen Fink

August 24, 2016

Pay-For-Delay & Stock Prices: Smoking Gun Or Damp Squib?

by Pierre Y. Cremieux, Ted Davis, Mark J. Lewis and Paul E. Greenberg

July 19, 2016

Stock Prices Aren’t Enough For ‘Rule Of Reason’ Analysis

by Pierre Y. Cremieux, Ted Davis, Mark J. Lewis and Paul E. Greenberg

Biosimilars

September 20, 2016

The Potential For Litigation In New Era Of Biosimilars

by Richard A. Mortimer and Alan White

April 13, 2016

Can The Life Sciences Industry Bank On Biosimilars?

by Paul E. Greenberg, Tamar Sisitsky and Richard A. Mortimer

Drug Pricing

May 17, 2016

False Claims Act

April 17, 2017

Tracing The Path To Health Care Investigation Settlements

by Kenneth Weinstein, Crystal Pike and Paul E. Greenberg

March 23, 2016

Correlation Or Cause: Brand-Name Drug Prescription Rates

by Paul E. Greenberg, Tamar Sisitsky and Richard A. Mortimer

February 9, 2009

Economic Analysis In Off-Label Promotion Cases

by Paul E. Greenberg and Tamar Sisitsky

Product Liability

January 29, 2014

What Attorneys Should Know About FDA’s MedWatch Data

by Mei Sheng Duh, Pierre Y. Cremieux, Paul E. Greenberg and Brian Ellman

July 3, 2012

How To Use Clinical-Trial Data In Court

by Pierre Y. Cremieux and Lisa B. Pinheiro